| SC 13G/A | 2019-10-10 | VANGUARD GROUP INC | Pacira BioSciences, Inc. | 4,431,828 | 10.6% | EDGAR |
| SC 13G/A | 2019-10-09 | BlackRock Inc. | Pacira BioSciences, Inc. | 6,758,949 | 16.2% | EDGAR |
| SC 13G | 2019-09-30 | INTEGRATED CORE STRATEGIES (US) LLC | Pacira BioSciences, Inc. | 603,347 | 1.4% | EDGAR |
| SC 13D/A | 2019-09-06 | Consonance Capital Management LP | Pacira BioSciences, Inc. | 2,075,970 | 4.9% | EDGAR |
| SC 13D/A | 2019-08-05 | Consonance Capital Management LP | Pacira BioSciences, Inc. | 2,340,089 | 5.7% | EDGAR |
| SC 13D/A | 2019-07-10 | Consonance Capital Management LP | Pacira BioSciences, Inc. | 2,789,916 | 6.8% | EDGAR |
| SC 13D/A | 2019-06-05 | Consonance Capital Management LP | Pacira BioSciences, Inc. | 3,205,559 | 7.8% | EDGAR |
| SC 13G/A | 2019-02-14 | HealthCor Management, L.P. | Pacira Pharmaceuticals, Inc. | 2,498,128 | 6.1% | EDGAR |
| SC 13G/A | 2019-02-14 | Partner Fund Management, L.P. | Pacira Pharmaceuticals, Inc. | - | 1.3% | EDGAR |
| SC 13G | 2019-02-14 | MACQUARIE GROUP LTD | Pacira Pharmaceuticals, Inc. | 2,136,332 | 5.2% | EDGAR |
| SC 13G/A | 2019-02-11 | BlackRock Inc. | Pacira Pharmaceuticals, Inc. | 3,331,529 | 8.1% | EDGAR |
| SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | Pacira Pharmaceuticals, Inc. | 3,785,145 | 9.2% | EDGAR |
| SC 13D | 2018-10-22 | Consonance Capital Management LP | Pacira Pharmaceuticals, Inc. | 3,652,134 | 8.9% | EDGAR |
| SC 13G | 2018-04-16 | Partner Fund Management, L.P. | Pacira Pharmaceuticals, Inc. | - | 5.9% | EDGAR |
| SC 13G/A | 2018-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | Pacira Pharmaceuticals, Inc. | 1,817,066 | 4.4% | EDGAR |
| SC 13G/A | 2018-02-14 | Point72 Asset Management, L.P. | Pacira Pharmaceuticals, Inc. | 651,000 | 1.6% | EDGAR |
| SC 13G/A | 2018-02-14 | HealthCor Management, L.P. | Pacira Pharmaceuticals, Inc. | - | 6.9% | EDGAR |
| SC 13G/A | 2018-02-14 | Partner Fund Management, L.P. | Pacira Pharmaceuticals, Inc. | - | 0.0% | EDGAR |
| SC 13G/A | 2018-02-09 | VANGUARD GROUP INC | Pacira Pharmaceuticals, Inc. | 3,253,501 | 8.0% | EDGAR |
| SC 13G/A | 2018-02-08 | BlackRock Inc. | Pacira Pharmaceuticals, Inc. | 3,292,397 | 8.1% | EDGAR |